713-47-3

Basic information

• Product Name: Benzoic acid,3-amino-5-fluoro-4-methyl-, ethyl ester
• Synonyms: 3-amino-5-fluoro-4-methylbenzoic acid ethyl ester;Benzoic acid,3-amino-5-fluoro-4-methyl-, ethyl ester;Ethyl 3-amino-5-fluoro-4-methylbenzoate
• CAS NO: 713-47-3
• Molecular Formula: C₁₀H₁₂FNO₂
• Molecular Weight: 197.21
• Mol File: 713-47-3.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 322.316°C at 760 mmHg
• Flash Point: 148.732°C
• Appearance: /
• Density: 1.184g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.533
• Storage Temp.: 2-8°C
• PKA: 2.34±0.10(Predicted)
• CAS DataBase Reference: Benzoic acid,3-amino-5-fluoro-4-methyl-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid,3-amino-5-fluoro-4-methyl-, ethyl ester(713-47-3)
• EPA Substance Registry System: Benzoic acid,3-amino-5-fluoro-4-methyl-, ethyl ester(713-47-3)

Safety Data

• Hazardous Substances Data: 713-47-3(Hazardous Substances Data)

Usage

General Description

Benzoic acid,3-amino-5-fluoro-4-methyl-, ethyl ester, also known as Ethyl 3-amino-5-fluoro-4-methylbenzoate, is a chemical compound with the molecular formula C11H12FNO2. Benzoic acid,3-amino-5-fluoro-4-methyl-, ethyl ester belongs to the class of organic compounds known as benzoic acid esters, which are ester derivatives of benzoic acid. It is characterized by the presence of a benzoic acid group (a carboxyl group bonded to a benzene ring) and an ester group (a carboxylic acid derivative that results from the condensation of a carboxylic acid and an alcohol). Its properties and reactivity can be influenced by these functional groups. It could potentially be used in the synthesis of other chemicals or as an intermediate in various chemical reactions.

InChI:InChI=1/C10H12FNO2/c1-3-14-10(13)7-4-8(11)6(2)9(12)5-7/h4-5H,3,12H2,1-2H3

Upstream product

• 2248-38-6 ethyl 3-fluoro-4-methyl-5-nitrobenzoate 
• 99069-09-7 ethyl 3-amino-4-methyl-5-nitrobenzoate 

Downstream Products

• 1095005-84-7 3-[(cyanomethyl)amino]-5-fluoro-4-methyl-benzoic acid, ethyl ester 
• 1095004-47-9 N-cyclopropyl-3-[3-[[1-[2-[2-[[(2S)-2-hydroxypropyl]amino]ethoxy]phenyl]cyclopropyl]amino]-2-oxo-1(2H)-pyrazinyl]-4-methyl-benzamide 
• 1095005-87-0 3-[5-bromo-3-[[1-methyl-1-[2-(phenylmethoxy)phenyl]ethyl]amino]-2-oxo-1(2H)-pyrazinyl]-N-cyclopropyl-5-fluoro-4-methyl-benzamide 
• 1095004-69-5 N-cyclopropyl-3-[3-[[1-[2-[2-(ethylamino)ethoxy]phenyl]-1-methylethyl]amino]-2-oxo-1(2H)-pyrazinyl]-5-fluoro-4-methyl-benzamide 
• 1095005-86-9 3-[5-bromo-3-[[1-methyl-1-[2-(phenylmethoxy)phenyl]ethyl]amino]-2-oxo-1(2H)-pyrazinyl]-5-fluoro-4-methyl-benzoic acid, ethyl ester 
• 1095005-89-2 3-[3-[[1-[2-(2-chloroethoxy)phenyl]-1-methylethyl]amino]-2-oxo-1(2H)-pyrazinyl]-N-cyclopropyl-5-fluoro-4-methyl-benzamide 
• 1095005-88-1 N-cyclopropyl-3-fluoro-5-[3-[[1-(2-hydroxyphenyl)-1-methylethyl]amino]-2-oxo-1(2H)-pyrazinyl]-4-methyl-benzamide 
• 1095005-85-8 3-(3,5-dibromo-2-oxo-1(2H)-pyrazinyl)-5-fluoro-4-methyl-benzoic acid, ethyl ester 

Relevant articles and documents

PYRAZINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF LUNG DISEASES

The present invention relates to py razinone derivatives of formula (I) wherein R1, R2, R3, R4, R5, R6 and R7 are as herein defined; processes for their preparation, pharmaceutical compositions containing them and their use in therapy.